[
  {
    "ts": "2026-02-17T04:34:55+00:00",
    "headline": "2 Value Stocks Worth Your Attention and 1 We Brush Off",
    "summary": "Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built their fortunes by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.",
    "url": "https://finance.yahoo.com/news/2-value-stocks-worth-attention-043455538.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "e5c8d940-5a5c-376f-85f0-0329922b79a3",
      "content": {
        "id": "e5c8d940-5a5c-376f-85f0-0329922b79a3",
        "contentType": "STORY",
        "title": "2 Value Stocks Worth Your Attention and 1 We Brush Off",
        "description": "",
        "summary": "Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built their fortunes by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.",
        "pubDate": "2026-02-17T04:34:55Z",
        "displayTime": "2026-02-17T04:34:55Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/a15915222ac7a28ad21e6f33116e18ba",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "FRSH Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rwldr1.Q9lrb1Z7CbpHvGg--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/a15915222ac7a28ad21e6f33116e18ba.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/av2kXnlfHIxoA8hKfbHqrw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/a15915222ac7a28ad21e6f33116e18ba.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/2-value-stocks-worth-attention-043455538.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/2-value-stocks-worth-attention-043455538.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VTRS"
            },
            {
              "symbol": "FRSH"
            },
            {
              "symbol": "BRBR"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-17T21:01:00+00:00",
    "headline": "HALOZYME REPORTS FULL YEAR 2025 RECORD REVENUE OF $1.4 BILLION AND REITERATES STRONG 2026 FINANCIAL GUIDANCE",
    "summary": "Halozyme Therapeutics, Inc. (NASDAQ: HALO) (\"Halozyme\" or the \"Company\") today reported its financial and operating results for the full year and fourth quarter ended December 31, 2025, and provided an update on its recent corporate activities.",
    "url": "https://finance.yahoo.com/news/halozyme-reports-full-2025-record-210100788.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "e79afaeb-e9df-3c43-b72d-95757a82d185",
      "content": {
        "id": "e79afaeb-e9df-3c43-b72d-95757a82d185",
        "contentType": "STORY",
        "title": "HALOZYME REPORTS FULL YEAR 2025 RECORD REVENUE OF $1.4 BILLION AND REITERATES STRONG 2026 FINANCIAL GUIDANCE",
        "description": "",
        "summary": "Halozyme Therapeutics, Inc. (NASDAQ: HALO) (\"Halozyme\" or the \"Company\") today reported its financial and operating results for the full year and fourth quarter ended December 31, 2025, and provided an update on its recent corporate activities.",
        "pubDate": "2026-02-17T21:01:00Z",
        "displayTime": "2026-02-17T21:01:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/c2d10463941059496c22a9967916bfb1",
          "originalWidth": 400,
          "originalHeight": 167,
          "caption": "Halozyme Therapeutics, Inc. Logo. (PRNewsFoto/Halozyme Therapeutics, Inc.) (PRNewsfoto/Halozyme Therapeutics, Inc.)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/g75kczZcd5MaZJYqyjNiSg--~B/aD0xNjc7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/c2d10463941059496c22a9967916bfb1.cf.webp",
              "width": 400,
              "height": 167,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/So_e66wwLJmH4i1xsBBqvA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/c2d10463941059496c22a9967916bfb1.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/halozyme-reports-full-2025-record-210100788.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/halozyme-reports-full-2025-record-210100788.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HALO"
            },
            {
              "symbol": "SKYE"
            },
            {
              "symbol": "RHHBF"
            },
            {
              "symbol": "TAK"
            },
            {
              "symbol": "VTRS"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]